LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Cells expressing a protein called p16INK4a, once thought to be associated with aging, have been found to aid tendon ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

Scientists studying aging may be taking an important step toward understanding how to preserve the body's cells as they grow ...

Epigenetics is an evolving field that is increasingly recognized as central to the understanding of biological aging.

A newly discovered molecule, OLE, restored the brain’s immune cells to a more protective state in Alzheimer’s disease models. The treatment reduced the accumulation of toxic plaques and improved ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

Pleased to announce the first patient has been dosed in our Phase 1 clinical trial, evaluating our lead candidate for optic ...

What are the most exciting advances in medicine on the horizon, the ones that could prevent or treat our biggest killers like ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.

A newly discovered molecule, OLE, restored the brain's immune cells to a more protective state in Alzheimer's disease models.